Endocannabinoid System Research: Cannabidiol’s Impact on Glucose Tolerance & Gut Health in Obese Adults
This pilot study examined cannabidiol gut microbiome obesity effects and found no significant improvement in glucose tolerance in sedentary overweight adults. While animal studies suggested metabolic benefits, these were not replicated here. Larger…
Investigating Cannabidiol’s Impact on Glucose Metabolism in Obesity
This study examines cannabidiol glucose metabolism obesity effects in sedentary overweight adults. Short-term low-dose CBD did not significantly improve glucose tolerance or alter gut microbiome composition. These findings suggest limited metabolic…
Investigating Cannabidiol’s Impact on Glucose Metabolism in Obesity
This pilot study investigates cannabidiol glucose metabolism obesity effects in overweight adults. Short-term low-dose CBD supplementation showed no significant improvements in glucose tolerance. The study also found no changes in gut microbiome…
Endocannabinoid System Research: CBD and Glucose Tolerance
This cannabidiol glucose tolerance clinical trial examined the effects of low-dose CBD on glucose metabolism in sedentary adults with overweight or obesity. The study found no significant improvements in glucose tolerance or gut microbiome changes after…
Changes in Levels of Endocannabinoidome Mediators in Mice with Cancer Cachexia
Cancer cachexia involves significant changes in the endocannabinoid system cancer cachexia mediators, affecting metabolism and gut health. This study in mice reveals links between these mediators and steatosis as well as gut microbial dysbiosis.…
Cannabidiol & Glucose Tolerance: Clinical Research Findings
This pilot study examined short-term low-dose cannabidiol supplementation and its effects on glucose tolerance. The findings showed no improvement in glucose tolerance or gut microbiome changes. Short-term low-dose cannabidiol use alone is unlikely to…
Research Digest: 20 Recent Studies – March 18, 2026
CED Clinical Relevance #85 Research Authority Peer-reviewed research curated for clinical relevance and evidence quality. Recent research digest. 20 of 20 most recent studies from our monitored feeds. CED Clinical Relevance #81 Research Authority…
Cannabinoid Clinical Trials: CBD, Glucose & Gut Health
This article reviews cannabinoid clinical trials CBD glucose effects on metabolic health. Short-term low-dose CBD supplementation showed no significant improvements in glucose tolerance or gut microbiome. These findings highlight the need for further…
Endocannabinoid System Clinical Research: CBD & Metabolic Health Insights
This pilot study examined cannabidiol glucose tolerance clinical trial evidence in sedentary adults with overweight or obesity. Results showed short-term low-dose CBD did not improve glucose tolerance or alter gut microbiome composition. These findings…